Journal of Cardiovascular Pharmacology and Therapeutics

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, D. Y.
Right arrow Articles by Mehtat, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, D. Y.
Right arrow Articles by Mehtat, J. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 7, No. 3, 147-153 (2002)
DOI: 10.1177/107424840200700304

Oxidized Low-Density Lipoprotein Receptor LOX-1 and Apoptosis in Human Atherosclerotic Lesions

D. Y. Li

H. J. Chen

Departments of Internal Medicine, Physiology and Biophysics, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, AR

E. D. Staples

K. Ozaki

Department of Surgery, University of Florida and the VA Medical Center, Gainesville, FL

B. Annex

Department of Medicine, Duke University School of Medicine, Durham, NC

B. K. Singh

Departments of Internal Medicine, Physiology and Biophysics, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, AR

R. Vermani

Department of Cardiovascular Pathology, Arned Forces Institute of Pathology, Washington, DC

J. L. Mehtat

Departments of Internal Medicine, Physiology and Biophysics, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, AR

Background: Lectin-like oxidized LDL receptor-I (LOX-1), a novel receptor for oxidized low-density lipoprotein, mediates oxidized low-density lipoprotein-induced apoptosis of endothelial cells, monocyte adhesion to endothelium, and phagocytosis of aged cells. The present study examined the role of LOX-1 and apoptosis in human atherosclerotic lesions.

Methods and Results: Grafted vein (n = 8), human carotid artery endarterectomy (n = 11), and normal human internal mammary artery (n = 8) specimens were used to study the expression of LOX-1 and apoptosis. LOX-1 expression was determined by reverse transcriptasepolymerase chain reaction, Western analysis, and immunostaining. Presence of apoptosis was determined by fluorescent in situ nick end-labeling staining and by the presence of poly (ADP-ribose) polymerase protein (an apoptotic marker). Expression of LOX-1 was significantly increased in atherosclerotic grafted vein and carotid artery specimens compared with that in normal arteries. LOX-1 was expressed in endothelial cells, macrophages, and smooth muscle cells. LOX-I was extensively expressed in the new blood vessels in the core of advanced atherosclerotic lesions. Double immunostaining showed LOX-1 expression to be colocalized with apoptotic cells. Fluorescent in situ nick end-labeling staining showed that the apoptotic cells were present mostly in the rupture-prone regions of the atherosclerotic plaque.

Conclusion: These observations indicate that LOX-I is extensively expressed in the proliferated intima of grafted veins and in advanced atherosclerotic carotid arteries. Further, LOX-1 is colocalized with apoptotic cells. These observations may relate to the phenomenon of plaque rupture, and provide targets for developing new therapies.

Key Words: apoptosis • atherosclerosis • LOX-1 • ox-low-density lipoprotein.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
HypertensionHome page
C. Hu, A. Dandapat, and J. L Mehta
Angiotensin II Induces Capillary Formation From Endothelial Cells Via the LOX-1 Dependent Redox-Sensitive Pathway
Hypertension, November 1, 2007; 50(5): 952 - 957.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. L. Mehta, N. Sanada, C. P. Hu, J. Chen, A. Dandapat, F. Sugawara, H. Satoh, K. Inoue, Y. Kawase, K.-i. Jishage, et al.
Deletion of LOX-1 Reduces Atherogenesis in LDLR Knockout Mice Fed High Cholesterol Diet
Circ. Res., June 8, 2007; 100(11): 1634 - 1642.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. L. Mehta, J. Chen, P. L. Hermonat, F. Romeo, and G. Novelli
Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): A critical player in the development of atherosclerosis and related disorders
Cardiovasc Res, January 1, 2006; 69(1): 36 - 45.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Chen, J. Chen, Y. Liu, J. Xie, D. Li, T. Sawamura, P. L. Hermonat, and J. L. Mehta
Adhesion Molecule Expression in Fibroblasts: Alteration in Fibroblast Biology After Transfection With LOX-1 Plasmids
Hypertension, September 1, 2005; 46(3): 622 - 627.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
M. Honjo, T. Sawamura, J. Hinagata, K. Nakamura, N. Sanada, H. Tanihara, Y. Honda, and J. Kiryu
Expression of LOX-1, an Oxidized Low-Density Lipoprotein Receptor, in Choroidal Neovascularization
Arch Ophthalmol, December 1, 2004; 122(12): 1873 - 1876.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. A. Lindstedt, M. J. Leskinen, and P. T. Kovanen
Proteolysis of the Pericellular Matrix: A Novel Element Determining Cell Survival and Death in the Pathogenesis of Plaque Erosion and Rupture
Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1350 - 1358.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
R Mango, F Clementi, P Borgiani, G B Forleo, M Federici, G Contino, E Giardina, L Garza, I E Fahdi, R Lauro, et al.
Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction
J. Med. Genet., December 1, 2003; 40(12): 933 - 936.
[Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. L. Mehta, B. Hu, J. Chen, and D. Li
Pioglitazone Inhibits LOX-1 Expression in Human Coronary Artery Endothelial Cells by Reducing Intracellular Superoxide Radical Generation
Arterioscler. Thromb. Vasc. Biol., December 1, 2003; 23(12): 2203 - 2208.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. E. Szmitko, C.-H. Wang, R. D. Weisel, G. A. Jeffries, T. J. Anderson, and S. Verma
Biomarkers of Vascular Disease Linking Inflammation to Endothelial Activation: Part II
Circulation, October 28, 2003; 108(17): 2041 - 2048.
[Full Text] [PDF]